Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: No higher DAT availability in patients with homozygosity for the 10-repeat allele

World Journal of Biological Psychiatry

Volumn 7, Issue 3, 2006, Pages 152-157

  Krause, Johanna ^a   Dresel, Stefan ^b   Krause, Klaus Henning ^c   La Fougère, Christian ^c   Zill, Peter ^b   Ackenheil, Manfred ^b  

^a Outpatient Clinic for Psychiatry and Psychotherapy   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Brain imaging techniques; DAT gene; Dopamine transporter (DAT); TRODAT 1 SPECT

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; DOPAMINE TRANSPORTER; IODINE 123; PROTEIN DAT1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CHROMOSOME 5P; CIGARETTE SMOKING; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; ETHNIC DIFFERENCE; FEMALE; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; IMAGING SYSTEM; KOREA; MAJOR CLINICAL STUDY; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGE FACTORS; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHROMOSOMES, HUMAN, PAIR 5; CORPUS STRIATUM; CROSS-CULTURAL COMPARISON; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EXONS; FEMALE; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; ORGANOTECHNETIUM COMPOUNDS; POLYMORPHISM, GENETIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 33746498351     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970500518444     Document Type: Article

References (33)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. WashingtonDC: American Psychiatric Association.
2. Bush, G and Valera, EM and Seidman, LJ. (2005) Functional neuroimaging of attention-deficit/hyperactivity disorder: A review and suggested future directions Biol Psychiatry, 57, pp. 1273-1284.
3. Castellanos, FX and Tannock, R. (2002) Neuroscience of attention-deficit/ hyperactivity disorder: The search for endophenotypes Nat Rev Neurosci, 3, pp. 617-628.
4. Chen, CK and Chen, SL and Mill, J and Huang, YS and Lin, SK and Curran, S and Purcell, S and Sham, P and Asherson, P. (2003) The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample Mol Psychiatry, 8, pp. 393-396.
5. Cheon, KA and Ryu, YH and Kim, JW and Cho, DY. (2005) The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: Relating to treatment response to methylphenidate Eur Neuropsychopharmacol, 15, pp. 95-101.
6. 123I]IPT SPET in children with attention deficit hyperactivity disorder Eur J Nucl Med, 30, pp. 306-311.
7. Cook, EH, Jr and Stein, MA and Krasowski, MD and Cox, NJ and Olkon, DM and Kieffer, JE and Leventhal, BL. (1995) Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet, 56, pp. 993-998.
8. Cornish, KM and Manly, T and Savage, R and Swanson, J and Morisano, D and Butler, N and Grant, C and Cross, G and Bentley, L and Hollis, CP. (2005) Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample Mol Psychiatry, 10, pp. 686-698.
9. Dougherty, DD and Bonab, AA and Spencer, TJ and Rauch, SL and Madras, BK and Fischman, AJ. (1999) Dopamine transporter availability in patients with attention deficit hyperactivity disorder Lancet, 354, pp. 2132-2133.
10. Dresel, S and Krause, J and Krause, KH and la Fougère, C and Brinkbäumer, K and Kung, HF and Hahn, K and Tatsch, K. (2000) Attention deficit hyperactivity disorder: Binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment Eur J Nucl Med, 27, pp. 1518-1524.
11. Faraone, SV and Perlis, RH and Doyle, AE and Smoller, JW and Goralnick, JJ and Holmgren, MA and Sklar, P. (2005) Molecular genetics of attention-deficit/hyperactivity disorder Biol Psychiatry, 57, pp. 1313-1323.
12. Gelernter, J and Kranzler, HR and Satel, SL and Rao, PA. (1994) Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia Neuropsychopharmacology, 11, pp. 195-200.
13. Gill, M and Daly, G and Heron, S and Hawi, Z and Fitzgerald, M. (1997) Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism Mol Psychiatry, 2, pp. 311-313.
14. Heinz, A and Goldman, D and Jones, DW and Palmour, R and Hommer, D and Gorey, JG and Lee, KS and Linnoila, M and Weinberger, DR. (2000) Genotype influences in vivo dopamine transporter availability in human striatum Neuropsychopharmacology, 22, pp. 133-139.
15. Jacobsen, LK and Staley, JK and Zoghbi, SS and Seibyl, JP and Kosten, TR and Innis, RB and Gelernter, J. (2000) Prediction of dopamine transporter binding availability by genotype: A preliminary report Am J Psychiatry, 157, pp. 1700-1703.
16. Kirley, A and Hawi, Z and Daly, G and McCarron, M and Mullins, C and Millar, N and Waldman, I and Fitzgerald, M and Gill, M. (2002) Dopaminergic system genes in ADHD: Toward a biological hypothesis Neuropsychopharmacology, 27, pp. 607-619.
17. Kirley, A and Lowe, N and Hawi, Z and Mullins, C and Daly, G and Waldman, I and McCarron, M and O'Donnell, D and Fitzgerald, M and Gill, M. (2003) Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD Am J Med Genet B Neuropsychiatr Genet, 121, pp. 50-54.
18. Krause, KH and Dresel, SH and Krause, J and Kung, HF and Tatsch, K. (2000) Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography Neurosci Lett, 285, pp. 107-110.
19. Krause, KH and Dresel, SH and Krause, J and Kung, HF and Tatsch, K and Ackenheil, M. (2002) Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder Int J Neuropsychopharmacol, 5, pp. 111-113.
20. Krause, KH and Dresel, SH and Krause, J and la Fougère, C and Ackenheil, M. (2003) The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder Neurosci Biobehav Rev, 27, pp. 605-613.
21. KrauseJ, la FougèreC, KrauseKH, AckenheilM, DreselSH. 2005. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci 255: 428-431.
22. Kung, HF and Kim, HJ and Kung, MP and Meegalla, SK and Plossl, K and Lee, HK. (1996) Imaging of dopamine transporters in humans with technetium-99m TRODAT-1 Eur J Nucl Med, 23, pp. 1527-1530.
23. Lott, DC and Kim, SJ and Cook, EH, Jr and de Wit, H. (2005) Dopamine transporter gene associated with diminished subjective response to amphetamine Neuropsychopharmacology, 30, pp. 602-609.
24. Madras, BK and Miller, GM and Fischman, AJ. (2005) The dopamine transporter and attention-deficit/hyperactivity disorder Biol Psychiatry, 57, pp. 1397-1409.
25. Martinez, D and Gelernter, J and Abi-Dargham, A and van Dyck, CH and Kegeles, L and Innis, RB and Laruelle, M. (2001) The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans Neuropsychopharmacology, 24, pp. 553-560.
26. Roman, T and Szobot, C and Martins, S and Biederman, J and Rohde, LA and Hutz, MH. (2002) Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder Pharmacogenetics, 12, pp. 497-499.
27. Sano, A. and Kondoh, K and Hakimoto, Y and Kondo, I. (1993) A 40-nucleotide repeat polymorphism in the human dopamine transporter gene Hum Genet, 91, pp. 405-406.
28. Spencer, TJ and Biederman, J and Madras, BK and Faraone, SV and Dougherty, DD and Bonab, AA and Fischman, AJ. (2005) In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: A focus on the dopamine transporter Biol Psychiatry, 57, pp. 1293-1300.
29. Stein, MA and Waldman, ID and Sarampote, CS and Seymour, KE and Robb, AS and Conlon, C and Kim, SJ and Cook, EH. (2005) Dopamine transporter genotype and methylphenidate dose response in children with ADHD Neuropsychopharmacology, 30, pp. 1374-1382.
30. Ujike, H and Harano, M and Inada, T and Yamada, M and Komiyama, T and Sekine, Y and Sora, I and Iyo, M and Katsu, T and Nomura, A and Nakata, K and Ozaki, N. (2003) Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis Pharmacogenomics J, 3, pp. 242-247.
31. van Dyck, CH and Quinlan, DM and Cretella, LM and Staley, JK and Malison, RT and Baldwin, RM and Seibyl, JP and Innis, RB. (2002) Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder Am J Psychiatry, 159, pp. 309-312.
32. Waldman, ID and Rowe, DC and Abramowitz, A and Kozel, ST and Mohr, JH and Sherman, SL and Cleveland, HH and Sanders, ML and Gard, JM and Stever, C. (1998) Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity Am J Hum Genet, 63, pp. 1767-1776.
33. Winsberg, BG and Comings, DE. (1999) Association of the dopamine transporter gene (DAT1) with poor methylphenidate response J Am Acad Child Adolesc Psychiatry, 38, pp. 1474-1477.